Complementary and Alternative Medicine
Oenanthe javanica flavone is a potent hepatitis B virus inhibitor
Published in Drug Week, July 8th, 2005
Investigators in the People's Republic of China conducted research "to study the antiviral effect of Oenanthe javanica flavones (OjF) on human hepatoma HepG2.2.15 culture system and duck hepatitis B virus (DHBV) infection."
"After incubation for 24 h, the 2.2.15 cells were treated with different concentrations of OjF for 12 days (d). Cell alteration was observed by microscope. The presence of HBsAg and HBeAg was measured using an enzyme immunoassay kit after 2.2.15 cells were treated with OjF for 9 d. (2) Ducklings infected with DHBV intravenously were divided into 5...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2005-07-08)
More Articles from Drug Week
- Anemia
Exploratory analysis of CERA data shows sustained and stable control of anemia - Cardiovascular Therapy
Valsartan/HCTZ combination is good for patients with added CV risk - Drug Development
Hematide clinical results demonstrate potent effect on red blood cell production - Drug Development
U.S. FDA grants tentative approval of Zolpidem ODT for sleep disorders - Rosacea
Oracea demonstrated up to a 61% reduction in inflammatory lesions in trial - Acetaminophen
Fever control in septic shock examined, benefit or harm probed - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
